Open spinal dysraphism

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:268369Q05.8Q05.9Q05.0
Who is this for?
Show terms as
21Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Open spinal dysraphism (OSD), also known as spina bifida aperta, is a group of congenital neural tube defects in which the spinal cord and/or its surrounding membranes are exposed through a defect in the vertebral arches and overlying skin. The most common forms include myelomeningocele (where the spinal cord and meninges protrude through the vertebral defect) and myelocele (where the neural placode is exposed at the skin surface). These defects occur during the first month of embryonic development when the neural tube fails to close properly. The condition primarily affects the nervous system, musculoskeletal system, and urogenital system. Key clinical features include motor and sensory deficits below the level of the lesion, lower limb weakness or paralysis, bowel and bladder dysfunction (neurogenic bladder and bowel), and orthopedic deformities such as clubfoot and hip dysplasia. Hydrocephalus is a frequent associated finding, occurring in approximately 80-90% of patients with myelomeningocele, often in association with Chiari II malformation. The severity of symptoms depends largely on the level and extent of the spinal defect, with higher (more cranial) lesions generally causing more extensive neurological impairment. Patients may experience loss of sensation, chronic pain, skin breakdown, and recurrent urinary tract infections. Tethered spinal cord can develop over time, leading to progressive neurological deterioration. Cognitive function is variable but can be affected, particularly when hydrocephalus is present. Treatment is multidisciplinary and typically begins with surgical closure of the defect within the first 24-48 hours of life to prevent infection and further neurological damage. Prenatal surgical repair (fetal surgery) has emerged as an option that may improve outcomes, as demonstrated by the MOMS (Management of Myelomeningocele Study) trial. Hydrocephalus is managed with ventriculoperitoneal shunting or endoscopic third ventriculostomy. Ongoing management includes urological care, orthopedic interventions, physical and occupational therapy, and neurosurgical surveillance. Folic acid supplementation before and during early pregnancy has been shown to significantly reduce the risk of neural tube defects. While there is no cure, comprehensive lifelong care can substantially improve quality of life and functional outcomes.

Also known as:

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Open spinal dysraphism.

View clinical trials →

No actively recruiting trials found for Open spinal dysraphism at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Open spinal dysraphism community →

Specialists

21 foundView all specialists →
IB
Ivonne Bedei
Specialist
3 Open spinal dysraphism publications
JH
Janka Held-Feindt
Specialist
2 Open spinal dysraphism publications
MS
Michael Synowitz
Specialist
2 Open spinal dysraphism publications
RA
Roland Axt-Fliedner
Specialist
2 Open spinal dysraphism publications
SK
Siegmund Köhler
Specialist
2 Open spinal dysraphism publications
FK
Friederike Knerlich-Lukoschus
Specialist
3 Open spinal dysraphism publications
CK
Corinna Keil
Specialist
3 Open spinal dysraphism publications
DM
DENISE A LAPA, MD
Specialist
PI on 1 active trial
PD
P L J DeKoninck
FORT WAYNE, IN
Specialist
1 Open spinal dysraphism publication
TS
T Struffert
Specialist
1 Open spinal dysraphism publication
MS
M Schulze
Specialist
1 Open spinal dysraphism publication
IB
I Bedei
Specialist
1 Open spinal dysraphism publication
CK
C C Kik
EUGENE, OR
Specialist
1 Open spinal dysraphism publication
RA
R Axt-Fliedner
Specialist
1 Open spinal dysraphism publication
SK
S Köhler
Specialist
1 Open spinal dysraphism publication
KM
Kuojen Tsao, MD
HOUSTON, TX
Specialist
PI on 1 active trial
SD
Stephen Fletcher, DO
Specialist
PI on 1 active trial3 Open spinal dysraphism publications
EP
Elizabeth A Thom, PhD
BLOOMINGTON, MN
Specialist
PI on 1 active trial
HB
Haibin Lin, bachelor
Specialist
PI on 1 active trial
HM
Heather H Said, MD
OMAHA, NE
Specialist
PI on 1 active trial
WV
W Ventura
Specialist
1 Open spinal dysraphism publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Open spinal dysraphism.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Open spinal dysraphismForum →

No community posts yet. Be the first to share your experience with Open spinal dysraphism.

Start the conversation →

Latest news about Open spinal dysraphism

No recent news articles for Open spinal dysraphism.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Open spinal dysraphism

What is Open spinal dysraphism?

Open spinal dysraphism (OSD), also known as spina bifida aperta, is a group of congenital neural tube defects in which the spinal cord and/or its surrounding membranes are exposed through a defect in the vertebral arches and overlying skin. The most common forms include myelomeningocele (where the spinal cord and meninges protrude through the vertebral defect) and myelocele (where the neural placode is exposed at the skin surface). These defects occur during the first month of embryonic development when the neural tube fails to close properly. The condition primarily affects the nervous system

How is Open spinal dysraphism inherited?

Open spinal dysraphism follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Open spinal dysraphism typically begin?

Typical onset of Open spinal dysraphism is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Open spinal dysraphism?

21 specialists and care centers treating Open spinal dysraphism are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.